Janux Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Janux Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Janux Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Janux Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.1M | 209k | 24.44 |
| 2025-03-31 | $3.7M | 135k | 27.00 |
| 2024-12-31 | $10M | 192k | 53.54 |
| 2024-09-30 | $836k | 18k | 45.43 |
| 2024-06-30 | $805k | 19k | 41.89 |
| 2024-03-31 | $728k | 19k | 37.65 |
| 2023-12-31 | $190k | 18k | 10.73 |
| 2023-09-30 | $1.5M | 149k | 10.08 |
| 2023-06-30 | $1.8M | 153k | 11.87 |
| 2023-03-31 | $1.4M | 117k | 11.78 |
| 2022-12-31 | $1.3M | 104k | 12.99 |
| 2022-06-30 | $1.3M | 104k | 12.50 |
| 2022-03-31 | $252k | 18k | 14.06 |
| 2021-12-31 | $264k | 13k | 19.84 |